JANANI Digital Health Platform has been launched by the Ministry of Health and Family Welfare. The platform aims to strengthen Maternal Care in India by creating a unified digital system for tracking care across pregnancy, childbirth, and...
Nutrition aid for TB patients, TB patients in India, and efforts to reduce tuberculosis deaths could save nearly 1.2 lakh lives every year, according to a new study that highlights the critical link between food support and tuberculosis treatme...
India’s pharma exports crossed the $31 billion mark in FY26 despite a challenging global business environment and slower demand in some international markets. The strong growth highlights the resilience of the Indian pharmaceutical indust...
In a significant development, an advisory panel of the U.S. Food and Drug Administration (FDA) has backed AstraZeneca’s prostate cancer combination therapy in a key vote, strengthening its chances of regulatory approval and offering new hop...
Pharmaceutical manufacturing workers form the backbone of resilient domestic and global drug supply chains. They operate in highly regulated, sterile environments to produce, package, and ensure the quality of essential medicines, from everyda...
Abbott has announced a major leap in AI coronary imaging with regulatory clearances for its new Ultreon 3.0 platform. The system has received approval from the U.S. Food and Drug Administration and the CE Mark, signaling readiness for use in...
A recent study by the All India Institute of Medical Sciences Patna has revealed a strong connection between brain injury and deaths caused by heatstroke. The research highlights how extreme heat can damage a critical part of the brain responsib...
India stands at the heart of the Oxford malaria vaccine pact, as the Serum Institute of India joins hands with the University of Oxford to push forward a next-generation malaria vaccine candidate, R78C. The partnership puts India in a key...
Max Healthcare Institute Ltd has joined a global dengue research initiative under the Indo-European COMBAT initiative to advance dengue science and pandemic readiness. The Max Healthcare dengue research initiative is supported by the Department...
Zydus Lifesciences Limited has received approval to begin Phase III clinical trials of Zintrodiazine for treating malaria in India, marking a key step in its push to develop new therapies against the disease. The company said the Zintrodiazine...